(Q33839000)

29 July 2017

1 reference

title

Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine (English)

1 reference

29 July 2017

1 reference

1 reference

Frickhofen N

1

1 reference

29 July 2017

Rosenfeld SJ

series ordinal

2

1 reference

29 July 2017

language of work or name

1 reference

1 January 2000

1 reference

29 July 2017

published in

Seminars in Hematology

1 reference

29 July 2017

volume

37

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

56-68

1 reference

The contribution of cyclosporine A to the understanding and treatment of autoimmune diseases

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Severe aplastic anaemia: correlation of in vitro test with clinical response to immunosuppression in 20 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Results of immunosuppression in 170 cases of severe aplastic anaemia. Report of the European Group of Bone Marrow Transplant (EGBMT).

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

A survey of the effectiveness of cyclophosphamide in patients with severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Effect of androgens on the response to antithymocyte globulin in patients with aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Transient pancytopenia. A report from the International Agranulocytosis and Aplastic Study

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Lymphocyte phenotype and lymphokines following anti-thymocyte globulin therapy in patients with aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Cyclosporine-induced autoimmunity and immune hyperreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Cyclosporin A in aplastic anemia--report of a workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Treatment of aplastic anemia with a monoclonal antibody directed against the interleukin-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Cyclosporine in refractory severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Cyclosporin A inhibits H2O2-induced apoptosis of human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Antilymphocyte immunoglobulins stimulate peripheral blood lymphocytes to proliferate and release lymphokines

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Effect of antilymphocyte globulin (ALG) on bone marrow T/non-T cells from aplastic anaemia patients and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

The use of antibodies against the IL-2 receptor in transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990030-1

7 January 2021

10.1016/S0037-1963(00)90030-1

Identifiers

DOI

1 reference

29 July 2017

1 reference